English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

The target of the survey is to study the efficacy of Enrofloxacin 5% and its lower doses used for the therapy of bovine anaplasmosis and efficacy of Enrofloxacin 2, 5 and 5% used for treatment of canine babesiosis. Enrofloxacin 5% has a pronounced therapeutic effect in treatment of anaplasmosis in cattle used at a dose of 1cm3 per 20 and 30 kg of body weight while using the preparation at a dose of 1cm3 per 40 and 50 kg of body weight the therapeutic effect was practically not observed. At the same time Enrofloxacin has no therapeutic efficacy against canine babesiosis.

Effect of Enrofloxacin for treatment of bovine anaplasmosis and canine babesiosis